Search Results
Dr. Weber on Adjuvant Approaches in Stage III Melanoma
Dr. Blank on Adjuvant Versus Neoadjuvant Approaches in Stage III Melanoma
Adjuvant and Neoadjuvant Therapy for Melanoma Weber 2021
Dr. Weber on Nivolumab in the Adjuvant Setting for Melanoma
Dr. Weber on Rationale for the CheckMate-238 Trial in Melanoma
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
Dr. Weber on CheckMate-238 Compared to Other Trials in Melanoma
Optimizing the Approach to Adjuvant Therapy for Resected Melanoma
Dr. Weber on Discontinuing Immunotherapy in Melanoma
Adjuvant Therapy Options in Melanoma
Dr. Eggermont on Responses to Adjuvant Pembrolizumab in Stage III Melanoma Subtypes
Adjuvant Therapy for Resected Stage III Melanoma
